Progressive Care Announces Record December and Full Year 2020 Performance Data
MIAMI, FL, Feb. 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”),...
Day: February 8, 2021
Orion and Bayer expand development program for darolutamide in prostate cancer
ORION CORPORATION PRESS RELEASE 8 FEBRUARY 2021 at 14.00 EET Orion and Bayer expand development program for darolutamide in...
Qilian International Holding Group Limited to Triple Organic Fertilizer Production Capacity by March 2021
Jiuquan, China, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical...
HEXO Corp appoints General Manager of US operations
OTTAWA, Feb. 08, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) announced today that...
Tauriga Sciences, Inc. Establishes Two Additional UPC Category Classifications for its Flagship Brand Tauri-Gum
TAUG These Additional Classifications are: Tauri-Gum™ Cases (8 Retail Boxes) & Tauri-Gum™ Shipment Crates (48 Retail Boxes) These Additional Classifications...
Initiation of stock buyback program
Please read the full announcement in the attached PDF Attachment 2021_05_Initiation_of_stock_buyback_program
Cytovance Biologics announces Regulatory Strategies for Gene Therapy Product Development webinar
OKLAHOMA CITY, Okla., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO)...
OvuSense announces partnership with ExSeed: a complete monitoring solution for the trying to conceive couple
WARWICK, United Kingdom, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Introducing the ultimate couple’s holistic approach to fertility, we are proud...
ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis
ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis The Independent Data Monitoring...
FDA grants Breakthrough Device Designation for Roche’s Elecsys Growth Differentiation Factor-15 (GDF-15) assay to help identify patients suitable for innovative treatment addressing unintentional weight loss in cancer patients
FDA BDD acknowledges the importance of GDF-15 testing in identifying eligible cachexic patients with solid tumours to be treated with...
Dentist Palatine IL Attains 100 Google Reviews Regency Dental Care Liana Tremmel
Dental treatment range has been updated by Liana Tremmel of Regency Dental Care in Palatine, IL. They have just received...
Ocugen Inc. Announces $23 Million Registered Direct Offering of Common Stock Priced at a Premium to Market
MALVERN, Pa., Feb. 07, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing...
Relay Medical Provides Update on Operations and Corporate Activity
Toronto, Ontario--(Newsfile Corp. - February 8, 2021) - Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) ("Relay" or the...
Sema4 Appoints Isaac Ro, Life Sciences Executive and Wall Street Veteran, as Chief Financial Officer
STAMFORD, Conn.--(BUSINESS WIRE)--#CFO--Sema4, a patient-centered health intelligence company, today announced the appointment of Isaac Ro as Chief Financial Officer (CFO)....
LENSAR to Present at Two Upcoming Investor Conferences
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser...
NextGen Healthcare’s Revenue Cycle Management Services Adopted by Loden Vision Centers
Prominent Ophthalmology Centers in Tennessee Increase Payments by 32 Percent Since Implementation ATLANTA--(BUSINESS WIRE)--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading...
Signifier Medical Ushers In New Era of Treatment for Sleep Apnea and Snoring with FDA Approval of eXciteOSA Device
Revolutionary first-ever daytime treatment for mild obstructive sleep apnea and snoring will now be available in the United States BOSTON...